Jon Stonehouse | BiotechTV

top of page

Search

BioCryst aims to leverage its commercial success to accelerate a robust pipeline based on structure-guided drug design

BioCryst aims to leverage its commercial success to accelerate a robust pipeline based on structure-guided drug design

BioCryst aims to leverage its commercial success to accelerate a robust pipeline based on structure-guided drug design

CEO Jon Stonehouse describes how making it across the finish line with Orladeyo has put BioCryst in a position after may decades of drug...

May 21, 2024

Follow BiotechTV

Also look for unique social pages for BiotechTV U.

Sponsors

NYSE_logo_large_no reg_378x197 (1).png

Learn more about our sponsors

Sponsor Spotlight

Allucent Clinical Research Organization™ is on a mission to help bring new therapies to light by solving the distinct challenges of small and mid-sized biotech companies. We’re a global provider of comprehensive drug development solutions, including consulting, clinical operations, biometrics, and clinical pharmacology across a variety of therapeutic areas.

Learn more about Allucent

bottom of page